Literature DB >> 7812075

Mechanisms of rapid bone loss following cardiac transplantation.

P N Sambrook1, P J Kelly, D Fontana, T Nguyen, A Keogh, P Macdonald, P Spratt, J Freund, J A Eisman.   

Abstract

Rapid bone loss after orthoptic cardiac transplantation (OHTX) is a major problem; however, the mechanisms are poorly understood. To investigate these mechanisms we measured biochemical and hormonal indices of bone turnover serially in 25 patients (21 men, 4 women) after OHTX. Serum osteocalcin was reduced immediately post-OHTX (2.2 +/- 0.5 ng/ml) but rose significantly by 6 and 12 months (14.1 +/- 2.5 and 15.7 +/- 2.2 respectively). Bone resorption indices (urinary hydroxyproline/creatinine and calcium/creatinine ratios) were increased immediately post-OHTX but fell by 6 months. Serum testosterone was reduced in males but recovered towards normal values by 6-12 months. Regression analysis showed lumbar bone loss was predicted independently by the change in both serum osteocalcin and testosterone. The data suggest that bone loss post-OHTX is due to a combination of accelerated turnover and hypogonadism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7812075     DOI: 10.1007/bf01623351

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  18 in total

1.  Reduced bone mineral density in men and women with allogeneic bone marrow transplantation.

Authors:  P J Kelly; K Atkinson; R L Ward; P N Sambrook; J C Biggs; J A Eisman
Journal:  Transplantation       Date:  1990-11       Impact factor: 4.939

2.  The Australian and New Zealand Cardiothoracic Organ Transplant Registry: first report 1984-1992.

Authors:  A M Keogh; A Kaan
Journal:  Aust N Z J Med       Date:  1992-12

3.  Genetic factors in bone turnover.

Authors:  P J Kelly; J L Hopper; G T Macaskill; N A Pocock; P N Sambrook; J A Eisman
Journal:  J Clin Endocrinol Metab       Date:  1991-04       Impact factor: 5.958

4.  Loss of vertebral bone density in heart transplant patients.

Authors:  J S Muchmore; D K Cooper; Y Ye; V T Schlegel; N Zuhdi
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

5.  Potential protection by cyclosporin against glucocorticoid effects on bone.

Authors:  P J Kelly; P N Sambrook; J A Eisman
Journal:  Lancet       Date:  1989-12-09       Impact factor: 79.321

6.  Age and menopause-related changes in indices of bone turnover.

Authors:  P J Kelly; N A Pocock; P N Sambrook; J A Eisman
Journal:  J Clin Endocrinol Metab       Date:  1989-12       Impact factor: 5.958

7.  Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration.

Authors:  C Movsowitz; S Epstein; M Fallon; F Ismail; S Thomas
Journal:  Endocrinology       Date:  1988-11       Impact factor: 4.736

8.  Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.

Authors:  P Sambrook; J Birmingham; P Kelly; S Kempler; T Nguyen; N Pocock; J Eisman
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

9.  Prediction of osteoporotic fractures by postural instability and bone density.

Authors:  T Nguyen; P Sambrook; P Kelly; G Jones; S Lord; J Freund; J Eisman
Journal:  BMJ       Date:  1993-10-30

10.  Rapid loss of vertebral mineral density after renal transplantation.

Authors:  B A Julian; D A Laskow; J Dubovsky; E V Dubovsky; J J Curtis; L D Quarles
Journal:  N Engl J Med       Date:  1991-08-22       Impact factor: 91.245

View more
  8 in total

Review 1.  Glucocorticoid-induced osteoporosis.

Authors:  P Boulos; G Ioannidis; J D Adachi
Journal:  Curr Rheumatol Rep       Date:  2000-02       Impact factor: 4.592

Review 2.  Vitamin D in organ transplantation.

Authors:  E M Stein; E Shane
Journal:  Osteoporos Int       Date:  2011-01-05       Impact factor: 4.507

3.  Zoledronic acid versus alendronate for the prevention of bone loss after heart or liver transplantation.

Authors:  Elizabeth Shane; Adi Cohen; Emily M Stein; Donald J McMahon; Chiyuan Zhang; Polly Young; Kavita Pandit; Ronald B Staron; Elizabeth C Verna; Robert Brown; Susan Restaino; Donna Mancini
Journal:  J Clin Endocrinol Metab       Date:  2012-09-28       Impact factor: 5.958

4.  Short-term systemic insulin-like growth factor-1 is unable to prevent cyclosporin A-induced osteopenia in the rat.

Authors:  G N Mann; D A Sass; H K Chen; F J Buchinsky; H P Bryer; Y F Ma; W S Jee; B Rucinski; S Epstein
Journal:  Calcif Tissue Int       Date:  1996-07       Impact factor: 4.333

5.  Serum testosterone levels after cardiac transplantation.

Authors:  Jessica Fleischer; Donald J McMahon; Wylie Hembree; Vicki Addesso; Christopher Longcope; Elizabeth Shane
Journal:  Transplantation       Date:  2008-03-27       Impact factor: 4.939

Review 6.  Osteoporosis after solid organ and bone marrow transplantation.

Authors:  Adi Cohen; Elizabeth Shane
Journal:  Osteoporos Int       Date:  2003-08-08       Impact factor: 4.507

7.  Show a heart for bones in time--fractures remain a common problem following cardiac transplantation.

Authors:  Harald Dobnig
Journal:  Wien Klin Wochenschr       Date:  2004-03-31       Impact factor: 2.275

8.  Endocrine disorders after heart transplantation: national cohort study.

Authors:  Matej Rakusa; Bojan Vrtovec; Gregor Poglajen; Andrej Janez; Mojca Jensterle
Journal:  BMC Endocr Disord       Date:  2020-04-20       Impact factor: 2.763

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.